Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06450509 · ClinicalTrials.gov registry record · NA

Proactive Speech and Language Intervention for Infants With Down Syndrome

A NA study of Down Syndrome, sponsored by Arizona State University.

Active
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06450509 is a NA study of Down Syndrome that is active but no longer recruiting, run by Arizona State University. The registered enrollment target is 60 participants, below the 2,471-participant average among 54 other Down Syndrome trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06450509, a NA study of Down Syndrome, is active but no longer recruiting, sponsored by Arizona State University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

Children with Down syndrome (DS) face life-long struggles with verbal communication. Babble and speech sound development is delayed, and speech can be difficult to understand. Words emerge late, at 21 months on average, compared to 12 months for typical peers, and vocabulary and grammar can remain limited throughout adulthood. Because DS is diagnosed at or even before birth, these difficulties are predictable; yet despite this prognostic knowledge, systematic and sustained proactive interventions have not yet been developed: Most children with DS are not assessed and treated for speech and language delays until age 2 to 4 years. This presents an untapped opportunity space to conduct a clinical trial of a proactive intervention in earliest infancy with the goal of building resilience against the anticipated difficulties. The intervention trialed here is a modified version of Babble Boot Camp (BBC), a proactive speech and language intervention originally developed for young infants with classic galactosemia (CG) (NIH 5R01HD098253). CG is a metabolic disease that, similar to DS, is diagnosed at birth and poses risks for severe speech and language delays. BBC is implemented by a speech-language pathologist who, via telehealth, trains parents to incorporate skill-building activities and routines into their daily lives at home. For the present study, 20 children with DS age birth to 12 months will be recruited and randomized into two treatment arms. One group will receive weekly individualized parent sessions and close monitoring of the child's progress. The second group will receive the same content but at a lower intensity and dosage, via monthly parent group meetings. Both groups will receive their intervention for 10 months. Specific aims are to quantify benefits for babble, speech production, and receptive and expressive language and to investigate associations between conversational dynamics in child-adult interactions and the children's speech and language. Outcome

Conditions Studied

Interventions

  • BEHAVIORAL Babble Boot Camp

Study Locations (1)

Arizona

  • Arizona State University - Tempe

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2024-02-28
Est. Completion 2026-03-30
Phase NA

Sponsor

Arizona State University

187 total trials

What the Registry Record Tells You About NCT06450509

The ClinicalTrials.gov registry entry for NCT06450509 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,471-participant average among 54 other Down Syndrome trials with a reported enrollment target (98% lower). The listed sponsor is Arizona State University, which has 187 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Down Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Babble Boot Camp is the first listed.

NCT06450509 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.

Frequently Asked Questions

What is clinical trial NCT06450509 about?

NCT06450509 is a clinical study titled "Proactive Speech and Language Intervention for Infants With Down Syndrome". Children with Down syndrome (DS) face life-long struggles with verbal communication. Babble and speech sound development is delayed, and speech can be difficult to understand. Words emerge late, at 21 months on average, compared to 12 months for typical peers, and vocabulary and grammar can remain l...

What is the current status of trial NCT06450509?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-02-28. Estimated completion is 2026-03-30.

What conditions does trial NCT06450509 study?

This clinical trial studies the following conditions: Down Syndrome.

What interventions are being tested in trial NCT06450509?

The interventions under investigation include: Babble Boot Camp (BEHAVIORAL).

Who is sponsoring clinical trial NCT06450509?

This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06450509 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Down Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.